Iron-acquisition–targeted therapy for multidrug-resistant Klebsiella pneumoniae: siderophore–antibiotic conjugates, clinical evidence, and emerging resistance
Biochimie · 2026-10 · 249 · 9-19
DOI: 10.1016/j.biochi.2026.06.014 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimie, 2026-10. Verfasst von Sayyidah Syathiroh Afzaruddin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Health Sciences, Universiti Teknologi MARA Cawangan Pulau Pinang, Bertam Campus, 13200, Kepala Batas, Penang, Malaysia. Hauptthemen laut MEDLINE: Klebsiella pneumoniae, Siderophores, Anti-Bacterial Agents, Iron. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 147 Literaturangaben. Gefördert von: Kementerian Pendidikan Malaysia.
Abstract (Originalsprache)
Carbapenem-resistant Klebsiella pneumoniae (K. pneumoniae) (CRKP) is the top-ranked critical-priority pathogen on the 2024 WHO Bacterial Priority Pathogens List, and the convergence of carbapenem resistance with hypervirulence (CR-hvKP) is now reported across all WHO regions. Because K. pneumoniae is exquisitely dependent on iron for survival in the host, iron-acquisition pathways have emerged as a tractable target for therapeutic exploitation. Siderophore-antibiotic conjugates (SACs) hijack the bacterium's TonB-dependent transporters via a "Trojan-horse" mechanism, delivering the antibiotic warhead across the otherwise impermeable Gram-negative outer membrane. Cefiderocol, the first clinically approved SAC, has reshaped treatment options for metallo-β-lactamase-producing Enterobacterales, but emerging resistance via mutations in TonB-dependent transporters (notably cirA), regulators (envZ-ompR, baeSR), and β-lactamase amplification threatens its long-term utility. We critically synthesise advances spanning from 2020 to 2026 in K. pneumoniae iron biology, host nutritional immunity, SAC chemistry, real-world clinical evidence, and resistance mechanisms, and define a research agenda centred on the kinetic as well as transcriptional dynamics of K. pneumoniae under prolonged iron starvation that must be addressed to safeguard this therapeutic frontier.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Health Sciences, Universiti Teknologi MARA Cawangan Pulau Pinang, Bertam Campus, 13200, Kepala Batas, Penang, Malaysia.
- Pusat Kanser Tun Abdullah Ahmad Badawi, Universiti Sains Malaysia, Bertam, 13200, Kepala Batas, Penang, Malaysia.
- Faculty of Health Sciences, Universiti Teknologi MARA Cawangan Pulau Pinang, Bertam Campus, 13200, Kepala Batas, Penang, Malaysia; Molecular Therapeutics and Cancer Translational Health (MATCH), Universiti Teknologi MAR…
Förderung
- Kementerian Pendidikan Malaysia
Zitieren
APA
Afzaruddin, S. S., Ishak, N. H., Hamid, S. B. S., Ismail, Z., & Shabani, N. R. M. (2026). Iron-acquisition–targeted therapy for multidrug-resistant Klebsiella pneumoniae: siderophore–antibiotic conjugates, clinical evidence, and emerging resistance. Biochimie, 249, 9-19. https://doi.org/10.1016/j.biochi.2026.06.014
Vancouver
Afzaruddin SS, Ishak NH, Hamid SBS, Ismail Z, Shabani NRM. Iron-acquisition–targeted therapy for multidrug-resistant Klebsiella pneumoniae: siderophore–antibiotic conjugates, clinical evidence, and emerging resistance. Biochimie. 2026;249:9-19. doi:10.1016/j.biochi.2026.06.014
BibTeX
@article{Afzaruddin2026,
author = {Afzaruddin, Sayyidah Syathiroh and Ishak, Nur Habibah and Hamid, Shahrul Bariyah Sahul and Ismail, Zakaria and Shabani, Nor Raihan Mohammad},
title = {Iron-acquisition–targeted therapy for multidrug-resistant Klebsiella pneumoniae: siderophore–antibiotic conjugates, clinical evidence, and emerging resistance},
journal = {Biochimie},
year = {2026},
volume = {249},
pages = {9--19},
doi = {10.1016/j.biochi.2026.06.014}
}
EUVIMED